{"nct_id":"NCT03547037","title":"A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2018-08-31","start_date_type":"ACTUAL","primary_completion_date":"2022-07-04","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}